Lockyer M. Diabetes therapy and cardiovascular outcomes. Practitioner 2016;260 (1796):9

Diabetes therapy and cardiovascular outcomes

23 Sep 2016Registered users

A large UK study  has shown clinically important differences in the risk of heart failure, cardiovascular disease (CVD), and all cause mortality in patients on different drugs, alone and in combination, for type 2 diabetes. Overall, use of gliptins or glitazones was associated with reduced risks of all three outcomes compared with non-use of these drugs.

Registered usersThis article can only be accessed if you are a registered user of thepractitioner.co.uk or a subscriber to The Practitioner.

To buy this article (£25+tax) copy the article citation above and click Buy article